Chicago, IL, (April 2, 2003) – New Phase III data presented today at the American College of Cardiology (ACC) 52nd Annual Scientific Session show that AstraZeneca’s investigational lipid-lowering ...
Crestor (rosuvastatin) is a brand-name oral tablet. It’s prescribed for reducing certain heart-related risks and lowering triglyceride and cholesterol levels. Crestor has interactions with some other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results